Get my own profile
Public access
View all24 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- David P FairlieProfessor, University of QueenslandVerified email at imb.uq.edu.au
- Timothy A HillSenior Reserch Officer, University of QueenslandVerified email at imb.uq.edu.au
- Rink-Jan LohmanVerified email at uq.edu.au
- Daniel S. NielsenCenter for Evolutionary Chemical Biology, Department of Chemistry, University of Copenhagen, DenmarkVerified email at chem.ku.dk
- Aline Dantas de AraujoInstitute for Molecular BioscienceVerified email at imb.uq.edu.au
- Paul YoungProfessor of Virology, University of QueenslandVerified email at uq.edu.au
- Ligong LiuGrand Medical Pty LtdVerified email at grandpharma.cn
- David J CraikUniversity of QueenslandVerified email at imb.uq.edu.au
- Michael WatersGroup Leader, Institute for Molecular Bioscience, University of QueenslandVerified email at uq.edu.au
- Christina I SchroederPeptide Therapeutics, Genentech, South San Francisco, CAVerified email at gene.com
- Robert ReidThe University of Queensland, Institute for Molecular BioscienceVerified email at imb.uq.edu.au
- Jacky Y SuenCritical Care Research Group, Faculty of Medicine, The University of Queensland, and The PrinceVerified email at uq.edu.au
- Eric LetouzéSenior Researcher, INSERM U1162Verified email at inserm.fr
- Alun JonesInstitute for Molecular BioscienceVerified email at imb.uq.edu.au
- Martin John StoermerUniversity of QueenslandVerified email at imb.uq.edu.au
- Kun SongAstraZenecaVerified email at astrazeneca.com
- Alan E. MarkProfessor of Biophysical Chemistry, University of QueenslandVerified email at uq.edu.au
- Alpesh MALDE (Alpeshkumar K MALD...Griffith UniversityVerified email at griffith.edu.au
- Weijun XuExperimental Drug Development Center